Cancer News and Research

Latest Cancer News and Research

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

30 Nov 2013

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

Using quantitative models of bacterial growth, a team of UC San Diego biophysicists has discovered the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the United States.

30 Nov 2013

EAUN launches new online course on bone health and urological cancer

The European Association of Urology Nurses launched a new online course for urology nurses and affiliated professionals "Bone health and urological cancer". This course tackles a highly pressing issue of maintaining and promoting bone health in cancer patients.

29 Nov 2013

Cyclin D1 protein controls cell cycle progression, microRNA biogenesis in breast cancer

Cyclin D1, a protein that helps push a replicating cell through the cell cycle also mediates the processing and generation of mature microRNA, according to new research publishing November 29 in Nature Communications. The research suggests that a protein strongly implicated in human cancer also governs the non-protein-coding genome. The non-coding genome, previously referred to as junk DNA, makes up most of the human genome, and unlike the coding genome, varies greatly between species.

29 Nov 2013

Ascend, 3M partner to develop and evaluate novel immunotherapy treatments for cancer

Ascend Biopharmaceuticals today announces that is has entered into an agreement with 3M Drug Delivery Systems to evaluate 3M’s Toll-Like Receptor 7/8 (TLR7/8) agonist 3M-051 in combination with Ascend’s proprietary cancer vaccine technology. The collaboration will support the creation and preclinical assessment of novel immunotherapy treatments to be potentially used for a number of different solid tumor types.

29 Nov 2013

Study brings effective hepatitis C cure closer to reality

Scientists at The Scripps Research Institute have determined the most detailed picture yet of a crucial part of the hepatitis C virus, which the virus uses to infect liver cells. The new data reveal unexpected structural features of this protein and should greatly speed efforts to make an effective hepatitis C vaccine.

29 Nov 2013

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

A study led by researchers at Boston University School of Medicine demonstrates a new mechanism involving a signaling protein and its receptor that may block the formation of new blood vessels and cancer growth. The findings are published in the December issue of Science Signaling.

29 Nov 2013

Sumitomo receives FDA 510(k) clearance for Proton Therapy System

Sumitomo Heavy Industries, Ltd. announced today that it had received US FDA 510(k) clearance of its Proton Therapy System. It is the first 510(k) cleared medical device for Sumitomo. Proton therapy is a form of radiation therapy, which employs proton beams to kill cancer cells with better dose distribution in comparison with conventional x-rays. Currently 12 facilities are operational and several more are under construction in the United States, and the U.S. proton therapy market is expected to expand in the future.

29 Nov 2013

Elevated cholesterol is associated with breast cancer risk

A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report.

29 Nov 2013

World's first clinical trial to use MLC tracking system to improve prostate cancer radiotherapy treatment

Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

28 Nov 2013

NHPA report compares performance of Queensland hospitals on cancer surgeries

Cancer Council Queensland has welcomed the first release of cancer surgery waiting times from the National Hospital Performance Authority.

28 Nov 2013

Medical Research Council should do more in the development of gold standard for clinical trial design

More should be done to celebrate the role of one of Britain’s leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.

28 Nov 2013

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.

28 Nov 2013

UK to fund over 70 new Centres for Doctoral Training

Details of how a -350 million fund will be used to train over 3,500 postgraduate students in engineering and physical sciences, will be announced today by Universities and Science Minister, David Willetts.

28 Nov 2013

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

What began two decades ago on Hilton Head Island as a free clinic using retired physicians and volunteers to care for the working poor has become a model for dozens of similar clinics nationwide. At a time when the nation debates how to pay for care, there are now 96 Volunteers in Medicine Clinics in 29 states (Smith, 11/27).

28 Nov 2013

Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery

A protector for PTEN, a tumor-thwarting protein often missing in cancer cells, has emerged from research led by scientists at The University of Texas MD Anderson Cancer Center published online at Nature Cell Biology this week.

28 Nov 2013

Improving the quality of cancer care among aging population

As 10,000 baby boomers reach 65 each day, the incidence of cancer is increasing, estimated to increase by 67% between 2010 and 2030, bringing attention to the nation's response to cancer care. Cancer is diagnosed at a higher rate, accounts for more survivors, and results in more deaths than in younger patients.

28 Nov 2013

Modafinil in combination with antidepressants reduces severity of depression more effectively

A new study has concluded that taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone.

28 Nov 2013

Longer looks: Providing dental care in rural Alaska; the after-effects of the ICU; cure for allergies

Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).

28 Nov 2013

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far.

27 Nov 2013

Cancer News and Research

Latest Cancer News and Research

Researchers develop series of techniques to create active iron-based catalysts

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

EAUN launches new online course on bone health and urological cancer

Cyclin D1 protein controls cell cycle progression, microRNA biogenesis in breast cancer

Ascend, 3M partner to develop and evaluate novel immunotherapy treatments for cancer

Study brings effective hepatitis C cure closer to reality

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

Sumitomo receives FDA 510(k) clearance for Proton Therapy System

Elevated cholesterol is associated with breast cancer risk

World's first clinical trial to use MLC tracking system to improve prostate cancer radiotherapy treatment

NHPA report compares performance of Queensland hospitals on cancer surgeries

Medical Research Council should do more in the development of gold standard for clinical trial design

Diagnosing colonic polyps: an interview with Dr. Haili Wang, Metabolomic Technologies Inc. (MTI)

UK to fund over 70 new Centres for Doctoral Training

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery

Improving the quality of cancer care among aging population

Modafinil in combination with antidepressants reduces severity of depression more effectively

Longer looks: Providing dental care in rural Alaska; the after-effects of the ICU; cure for allergies

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in